MFG
CORT icon

Merit Financial Group’s Corcept Therapeutics CORT Stock Holding History

Merit Financial Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+11,908
New +$719K 0.01% 1063
2025
Q4 		– Sell
-3,808
Closed -$316K – 1968
2025
Q3 		$316K Buy
3,808
+1,011
+36% +$73.2K ﹤0.01% 1420
2025
Q2 		$205K Buy
2,797
+198
+8% +$14.4K ﹤0.01% 1542
2025
Q1 		$297K Buy
+2,599
New +$158K ﹤0.01% 1123

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Merit Financial Group's CORT Position: Q2 2026 in Review

Merit Financial Group opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 11,908 shares worth $1.04M. The stake represents 0.01% of the portfolio and ranks #1063 among its holdings. This is a return to the name: Merit Financial Group previously reported a position in CORT as recently as Q3 2025.

Merit Financial Group first reported a position in CORT in Q1 2025 and has held it in 4 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Merit Financial Group held 11,908 shares of Corcept Therapeutics worth $1.04M as of Q2 2026.
  • Corcept Therapeutics was a new Merit Financial Group position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of Merit Financial Group's portfolio in Q2 2026, its #1063 holding.
  • Merit Financial Group first reported a position in Corcept Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.